MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis
Jeffrey B. Kopp(National Institute of Diabetes and Digestive and Kidney Diseases), Cheryl A. Winkler(Frederick National Laboratory for Cancer Research), Jeffrey S. Berns(University of Pennsylvania), Howard Trachtman(University of Michigan), Michele H. Mokrzycki(Conservatoire National des Arts et Métiers), Louise M. McKenzie(National Cancer Institute), Monique E. Cho(University of Utah), Hiroshi Kajiyama(National Institutes of Health), Michael W. Smith(National Cancer Institute), Donald W. Bowden(Wake Forest University), Randall C. Johnson(Conservatoire National des Arts et Métiers), David Vlahov(Yale University), Stephen M. Korbet(Rush University Medical Center), Jeffrey R. Schelling(Case Western Reserve University), Tarás K. Oleksyk(Oakland University), Barry I. Freedman(Wake Forest University), George W. Nelson(Division of Undergraduate Education), Paul L. Kimmel(Anna Needs Neuroblastoma Answers), W Briggs(Beaumont Hospital, Royal Oak), Tejinder S. Ahuja(Frederick National Laboratory for Cancer Research), Richard A. Dart(Marshfield Clinic), Eric E. Simon(Division of Undergraduate Education), Donna M. Michel(Science Applications International Corporation (United States))
Cited by 706
Related Papers
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the <i>CKR5</i> Structural Gene
|Science|1996|2.5k
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
|Science|2004|1.2k
Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III
|Nature Genetics|1997|869